Clinical significance of PIK3CA and ESR1 mutations in ctDNA and FFPE samples from the MONARCH 2 study of abemaciclib plus fulvestrant Tolaney, S. M., Toi, M., Neven, P., Sohn, J., Grischke, E., Llombart-Cussac, A., Soliman, H., Litchfield, L. M., Wijayawardana, S., Forrester, T., Jansen, V. M., Sledge, G. W. AMER ASSOC CANCER RESEARCH. 2019

View details for DOI 10.1158/1538-7445.AM2019-4458

View details for Web of Science ID 000488279404337